Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideELVElevance Health
FinDog View：Neutral
JNJJohnson & Johnson
FinDog View：Bullish
| Metric | ELV | JNJ |
|---|
| Close | 412.56 | 267.28 |
| Market Cap | $89.5B | $644B |
| 1M | +5.72% | +1.87% |
| P/E (TTM) | 18.2 | 30.6 |
| Forward P/E | 13.2 | 20.7 |
| P/E 5-Yr Percentile | 71 | 90 |
| P/S | 0.5 | 6.6 |
| P/B | 2.0 | 7.6 |
| Dividend Yield | 1.24% | 3.12% |
| Latest Quarter Revenue | $50.5B | $25.3B |
| Revenue YoY | +1.4% | +6.6% |
| Gross Margin | 89.1% | 68.2% |
| Latest Quarter EPS | 6.71 | 2.27 |
| Avg Post-Earnings Move | ±4.0% | ±0.6% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 4.70% | 1.25% |
| 90-Day Net Insider Buying | +$1.4M | −$67.8M |
ELV · Revenue, Last 8 Quarters ($B)
JNJ · Revenue, Last 8 Quarters ($B)
